Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New burn cream aims to speed healing in phase 2 trial

NCT ID NCT01297400

First seen Nov 06, 2025 · Last updated Jun 18, 2026 · Updated 30 times

Summary

This study tests a new cream called MW-III on partial-thickness thermal burns (like from fire or hot liquids). It compares MW-III to a standard burn cream, Silvadene, to see which helps burns heal faster. About 60 adults with burns covering up to 25% of their body will take part. The main goal is to measure time to 95% healing.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BURNS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • MedStar Washington Hospital Center

    RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • Proactive CR Mexico SA de CV

    RECRUITING

    Irapuato, Mexico

  • SMIQ S de R. L de CV

    RECRUITING

    Querétaro City, Mexico

  • University of CA Davis Medical Center

    RECRUITING

    Sacramento, California, 95817, United States

  • University of Iowa Health Care

    RECRUITING

    Iowa City, Iowa, 52242, United States

  • Valleywise Health Medical Center

    RECRUITING

    Phoenix, Arizona, 85008, United States

Conditions

The condition(s) this trial relates to.

burn

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.